시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 좌골신경통 시장 보고서(2025년)
Sciatica Global Market Report 2025
상품코드 : 1825546
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

좌골신경통 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 6.0%로 92억 3,000만 달러로 성장합니다. 예측 기간의 성장은 맞춤형 의료, 원격의료 및 원격 시술, 환자 교육 및 인식 개선, 상환 정책 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향에는 첨단 영상 진단, 재생의료, 디지털 치료, 예방대책 등이 포함됩니다.

향후 5년간 6.0%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 인도와 멕시코에서 수입되는 경막외 스테로이드 주사 키트와 신경차단제 비용을 상승시킴으로써 미국의 의료 공급망을 혼란에 빠뜨릴 수 있으며, 통증 관리 비용 증가와 환자 치료 지연을 초래할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

정형외과수술 증가는 향후 좌골신경통 시장의 성장을 촉진할 것으로 예측됩니다. 척추, 관절, 골격계에 영향을 미치는 증상을 다루는 정형외과적 시술은 고령화, 근골격계 질환의 유병률 증가, 신체 활동 및 스포츠 참여 증가 등의 요인으로 인해 증가 추세에 있습니다. 좌골 신경을 따라 통증을 유발하는 좌골신경통은 통증 완화, 운동성 회복, 삶의 질 향상을 위해 정형외과 의사나 외과 의사가 관여하는 치료가 필요한 경우가 많습니다. 예를 들어 국립의학도서관이 2023년 2월 발표한 연구에 따르면 2040년까지 인공고관절 전치환술(THA)과 인공슬관절 전치환술(TKA) 수술 건수가 크게 증가하여 THA 수술 건수는 71만 9,364건, TKA 수술 건수는 122만 2,988건 증가할 것으로 예측했습니다. 2060년까지 TKA는 291만 7,959건, THA는 198만 2,099건에 달할 것으로 예측됩니다. 정형외과수술이 증가함에 따라 좌골신경통 관련 치료 및 요법에 대한 수요도 증가하여 시장 성장에 박차를 가할 것으로 보입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Sciatica is characterized by pain resulting from inflammation, irritation, or compression of the sciatic nerve, typically occurring in the leg due to pressure or injury. Physical therapy proves effective in alleviating sciatica by enhancing flexibility, strength, and range of motion, thereby reducing pressure on the affected nerve.

There are several types of sciatica, including acute and chronic sciatica. Acute sciatica is characterized by lower back pain that can last for up to six weeks and is typically caused by pressure or injury to the sciatic nerve. Treatment options for sciatica encompass a variety of drugs such as oxycodone, tramadol, opioid analgesics, amitriptyline, tricyclic antidepressants, among others. Additionally, treatments may involve medication regimens and surgical interventions, catering to a diverse range of end-users including hospitals, homecare, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The sciatica market research report is one of a series of new reports from The Business Research Company that provides sciatica market statistics, including sciatica industry global market size, regional shares, competitors with a sciatica market share, detailed sciatica market segments, market trends and opportunities and any further data you may need to thrive in the sciatica industry. This sciatica market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sciatica market size has grown strongly in recent years. It will grow from $6.93 billion in 2024 to $7.31 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to innovative pain management solutions, digital health, telemedicine, personalized treatment approaches, integrative care models.

The sciatica market size is expected to see strong growth in the next few years. It will grow to $9.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote procedures, patient education and awareness, reimbursement policies. Major trends in the forecast period include advanced diagnostic imaging, regenerative medicine, digital therapeutics, preventive measures.

The forecast of 6.0% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. medical supply chains by increasing costs for epidural steroid injection kits and nerve block agents imported from India and Mexico, potentially leading to higher pain management expenses and delayed relief for patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of orthopedic procedures is expected to drive the growth of the sciatica market going forward. Orthopedic procedures, which address conditions affecting the spine, joints, and skeletal system, are on the rise due to factors such as an aging population, a higher prevalence of musculoskeletal disorders, and growing participation in physical activities and sports. Sciatica, which causes pain along the sciatic nerve, often requires treatment that can involve orthopedic doctors and surgeons to alleviate pain, restore mobility, and improve quality of life. For example, a February 2023 study published by the National Library of Medicine forecasted that total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures would increase significantly by 2040, with THA procedures growing by 719,364 and TKA procedures rising by 1,222,988. By 2060, the number of TKAs is expected to reach 2,917,959, while THAs will total 1,982,099. As orthopedic surgeries increase, so too will the demand for treatments and therapies related to sciatica, fueling market growth.

The growing prevalence of back problems is expected to propel the growth of the sciatica market. Back problems refer to various mechanical or structural issues in the spine, discs, muscles, ligaments, or tendons, as well as nerve compression in the back. Individuals with back issues are at higher risk of developing sciatica, a condition characterized by pain along the sciatic nerve. As back problems become more common, there is an increased demand for treatments and solutions to alleviate sciatica pain. For example, a study conducted by the University of Sydney in May 2023 analyzed over 30 years of data and found that the number of cases of low back pain is on the rise. Projections indicate that by 2050, 843 million people will be affected by low back pain, largely due to population growth and aging. This growing prevalence of back problems is driving the demand for sciatica treatments, fueling the market's expansion.

Prominent companies in the sciatica market are actively engaged in the development and approval of innovative products in collaboration with federal agencies, as a strategic move to maintain their market standing. These advancements in sciatica therapy not only offer improved treatment options but also serve to mitigate side effects, enhance overall efficacy, and broaden the spectrum of available treatments. For instance, in June 2022, SciatiEase Labs, a US-based health supplement company, achieved approval for its product "SciatiEase" from the United States Food and Drug Administration (FDA), a federal agency in the United States. SciatiEase is a powerful supplement that amalgamates various beneficial elements into a single pill, designed to alleviate sporadic discomfort associated with sciatic nerve pain. These supplements are specifically crafted for individuals who regularly grapple with discomfort along the sciatic nerve and may face dietary restrictions that hinder their ability to naturally alleviate such discomfort.

In April 2023, Nura Pain Clinics, a US-based medical practice clinic, merged with Capitol Pain Institute Inc. for an undisclosed amount. This merger is poised to deliver an innovative and integrated approach to care, all while maintaining their shared commitment to aiding individuals enduring chronic pain. Capitol Pain Institute Inc., an American clinic specializing in interventional pain care, caters to a range of conditions, including sciatica and back pain.

Major companies operating in the sciatica market are Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Intas Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., Lupin Limited, Alkem Laboratories Limited, Torrent Pharmaceuticals Ltd.

North America was the largest region in the sciatica market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sciatica report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sciatica market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sciatica market consists of revenues earned by entities by providing services such as medication and heat therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The sciatica market also includes sales of muscle relaxants, which are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sciatica Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sciatica market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sciatica ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sciatica market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Sciatica Market Characteristics

3. Sciatica Market Trends And Strategies

4. Sciatica Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sciatica Growth Analysis And Strategic Analysis Framework

6. Sciatica Market Segmentation

7. Sciatica Market Regional And Country Analysis

8. Asia-Pacific Sciatica Market

9. China Sciatica Market

10. India Sciatica Market

11. Japan Sciatica Market

12. Australia Sciatica Market

13. Indonesia Sciatica Market

14. South Korea Sciatica Market

15. Western Europe Sciatica Market

16. UK Sciatica Market

17. Germany Sciatica Market

18. France Sciatica Market

19. Italy Sciatica Market

20. Spain Sciatica Market

21. Eastern Europe Sciatica Market

22. Russia Sciatica Market

23. North America Sciatica Market

24. USA Sciatica Market

25. Canada Sciatica Market

26. South America Sciatica Market

27. Brazil Sciatica Market

28. Middle East Sciatica Market

29. Africa Sciatica Market

30. Sciatica Market Competitive Landscape And Company Profiles

31. Sciatica Market Other Major And Innovative Companies

32. Global Sciatica Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sciatica Market

34. Recent Developments In The Sciatica Market

35. Sciatica Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기